Trump's former FDA commissioner: ‘It will cost lives in this country' if RFK Jr. follows through on intentions
Dr. Scott Gottlieb, Trump’s former FDA commissioner, said he has concerns about the president-elect’s pick for health ...
US Supreme Court wrestles with FDA denial of flavored vape products
The U.S. Supreme Court grappled on Monday with the U.S. Food and Drug Administration's defense of the agency's refusal to let ...
US Supreme Court examines FDA denial of flavored vape products
The U.S. Supreme Court began hearing arguments on Monday in the U.S. Food and Drug Administration's defense of the agency's ...
Pie Recall Update As FDA Sets Most Serious Risk Level
Products sold in the Northwest have been given the highest risk status, but so far no illnesses have been reported.
CDC, FDA probe tainted cucumbers that sickened 68 people in 19 states
Federal and state health officials said Friday they are working to track down more information about a Salmonella outbreak ...
Trump’s former FDA commissioner warns RFK Jr. could ‘cost lives’ if confirmed
Scott Gottlieb said he’s worried that Trump’s pick to run HHS, Robert F. Kennedy Jr., will follow through on past antivaccine ...
Ex-FDA Commissioner Says RFK Jr. 'Will Cost Lives' As Head Of Health Department
Scott Gottlieb, who served early on in Trump's first term, is now warning senators about the impact Kennedy could have on ...
FDA leader during Trump’s first term sounds alarm on RFK Jr’s potential plans: ‘It will cost lives’
Trump administration pick for Health and Human Services department could cause rise in preventable disease, health expert ...
Supreme Court Weighs FDA Ban on Sweet Vapes Amid Youth Vaping Spike
The U.S. Supreme Court will hear arguments Monday on whether to reinstate a federal ban on sweet-flavored vaping products.
FiercePharma5h
FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports
The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona and ...
Biotech Stocks Facing FDA Decision In December 2024
The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step ...